If the ENMD (or any other anti-ang) drugs aresuccessful, wouldn't that put SUPG in an unfavorablecompetitive position? If the ant-ang drugs are effective whatwould the market be for SUPG's anti-cancer drugs? Anyresponses appreciated. Thanks.
seems to me that getting FDA approval is a BIGTHING, but the stock is not acting like it....So manyshares traded and the stock price is doing nothing,NADA, ,,,,,too bad Im long by 2000 at 15.5 UGH!